Valley National Advisers Inc. Has $191,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Valley National Advisers Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 481 shares of the medical equipment provider’s stock after purchasing an additional 122 shares during the quarter. Valley National Advisers Inc.’s holdings in Intuitive Surgical were worth $191,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Baystate Wealth Management LLC increased its stake in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC increased its stake in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the period. Able Wealth Management LLC bought a new position in Intuitive Surgical during the 4th quarter worth $28,000. Atticus Wealth Management LLC increased its stake in shares of Intuitive Surgical by 85.4% in the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 41 shares during the last quarter. Finally, MeadowBrook Investment Advisors LLC bought a new position in shares of Intuitive Surgical in the 4th quarter valued at $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 175 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $389.16, for a total value of $68,103.00. Following the completion of the transaction, the senior vice president now directly owns 883 shares of the company’s stock, valued at $343,628.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, SVP Mark Brosius sold 175 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $389.16, for a total value of $68,103.00. Following the completion of the transaction, the senior vice president now directly owns 883 shares of the company’s stock, valued at $343,628.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total value of $589,484.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,956 shares of company stock valued at $6,927,011. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Trading Down 0.9 %

Intuitive Surgical stock traded down $4.00 during midday trading on Wednesday, reaching $434.81. The stock had a trading volume of 824,148 shares, compared to its average volume of 1,519,161. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $448.10. The company has a market capitalization of $154.23 billion, a P/E ratio of 78.55, a PEG ratio of 5.75 and a beta of 1.39. The company has a fifty day moving average price of $406.41 and a two-hundred day moving average price of $385.08.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s revenue was up 11.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.00 EPS. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ISRG has been the topic of several recent analyst reports. Robert W. Baird decreased their price target on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Stifel Nicolaus lifted their price target on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Piper Sandler lifted their price target on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. Citigroup lifted their price target on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Finally, BTIG Research raised their price objective on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a report on Friday, April 19th. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $404.79.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.